Author Guidelines
Aim and Scope:
Journal of Current Biomedical Reports is an open access, peer-reviewed journal which accepts different types of papers in all aspects of basic medical sciences to facilitate and enhance the global exchange of knowledge. The Editorial Board consists of outstanding specialists in biomedical research that guarantee accuracy and quality of peer-review process for submitted manuscripts. We are eager to receiving submissions from all over the world particularly high-quality papers presenting advances in their own research fields. The general fields of interest are the current clinical researches in the fields of Bacteriology, Virology, Parasitology, Mycology, Biochemistry, Immunology, Hematology, Physiology, Epidemiology, Biotechnology, Molecular Biology, Pharmacology, Nanotechnology, and other related topics.
General Information
Submitted manuscripts that considered for publication must be original work of authors, and have not been published or under consideration for publication elsewhere. Abstracts presented in conferences which not published as a supplementary issue do not constitute prior publication. Manuscripts are publishable in the form of original articles, brief reports, review articles (systematic and narrative), case reports, and letters to the editor. The Journal frequency is quarterly.
The instructions for authors include information about preparing a manuscript for submission, criteria for publication, and the online submission process. We recommend that you take the time to read them before submitting a contribution to JCBR. Other relevant information about the journal can be found in “About the journal”.
Submission process:
All manuscripts should be submitted using the online submission system available at the journal’s homepage “Online submission”. Also, all the publication process include checking the latest status of the manuscript, responding, and sending the revision should be followed on our online system.
*** Upon the new registration, ensure to checking the "Author" box as shown in the image below***
Manuscript preparation
Generally, the following formats should proceed for a submitted manuscript:
- Microsoft Word (DOC, DOCX)
- Double line space
- Fonts 12 Times New Roman
- Continues page numbering at bottom of the pages
- To ensuring a blind review, insert the Title page on a separate page.
- Cover letter, Figure original file, and other supporting files should be uploaded in submission step 4 as a supplementary file.
Cover letter:
All of the submitted manuscripts should be accompanied by a cover letter that contains the rationale of performing the research and selecting the JCBR as well as a statement that the proposed manuscript is not published or under consideration in another journal until the reviewing process completed. Also please indicate whether the authors have published or submitted any related papers from the same study. Finally any possible conflicts of interest must be clearly declared.
Title Page:
The title page must be included in a separate page and contain the type of article, the title of work, running title or short title (not exceeding 50 characters including spaces), the full name of the author(s), affiliation(s) and detailed information of the corresponding author(s) include the name(s), degree, phone and fax number, email, and current working address. We strongly recommend providing ORCID ID for the corresponding author(s).
Abstract and Keywords:
The manuscript must be accompanied by a non-structured abstract prepared in both English and Persian. Abstracts should be no more than 250 words for original and review articles, and no more than 150 words for brief and case reports. For non-Iranian authors, the Persian translation of abstract is made by English editor at no extra cost.
Immediately after the abstract, provide 3-5 keywords representing the main content of the article which separated by comma (,). Try to use the keywords that are not repeated in the title of work.
Main text:
Original articles: This type of article must include an introduction, materials (patients) and methods, results, discussion, conclusions, and references. The length of the paper must not exceed 4,000 words excluding the references, abstract, figures, and tables.
Brief reports: This type of article must include introduction, materials (patients) and methods, results, discussion, conclusions, and references. The length of the paper must not exceed 1,500 words excluding the references, abstract, figures, and tables. Only two tables or figures allowed.
Narrative review articles: No restricted structure followed for this type of article, but the text should be divided into sections by suitable headings, and include a comprehensive conclusion. The use of appropriate tables and figures are also encouraged.
Systematic reviews and meta-analysis: This type of article must include introduction, materials and methods, results, discussion, conclusions, and references.
Case reports: This type of article must include an introduction, case presentation, discussion, conclusion, acknowledgment (if applicable), and references. In a case report, the maximum number of tables or figures is two and references are 20. The length should not exceed 1500 words. Informed consent should be obtained from the patients to report their cases.
Letters to the Editor: Three types of letters are welcomed, 1) commenting on a recently published article, 2) a brief review on a hot or new topic by one of the Editorial board, and 3) reporting limited original research. The length of the letters should be no more than 500 words. The letters should not contain an abstract, subheadings, more than 20 references, and two tables and figures.
Erratum: To better serve our audience, JCBR accepts Erratum or Publisher Correction for the error made by either the journal or authors during the publication process of a published article. You can submit your Erratum as a new submission via our online system in a Microsoft Word file. After peer-review it will be linked to the original file of the article.
References:
Citation in text:
Please ensure that every reference cited in the main text is also included in the reference list (and vice versa). Using unpublished results and personal communications are not acceptable in the reference list but can be used as a quotation in the text. Reference citation numbers should be consecutively and placed in square brackets [1], or [1-3]. All the references cited in the main text should be listed as they appear in the text at the end of the manuscript under a separate heading entitled “References”.
Reference style
Standard Vancouver reference style should be followed as shown below:
Journal articles:
1. Cheng MF, Chen WL, Hung WY, Huang IF, Chiou YH, Chen YS, et al. Emergence of extended spectrum-beta-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants. Pediatr Infect Dis J. 2015;34(5):469-75.
2. Karimi A, Fakhimi-Derakhshan K, Imanzadeh F, Rezaei M, Cavoshzadeh Z, Maham S. Helicobacter pylori infection and pediatric asthma. Iran J Microbiol. 2013 Jun;5(2):132-5.
Book chapters:
Author(s) of chapter. Title of chapter. In: Editor(s) of book, editors. Title of book. edition (if not first). Place of publication: Publisher name; Year of publication. p. [page numbers of chapter].
Online documents:
Author/organization's name (if available). Title of the page [Internet]. Place of publication: Publisher's name; Publication date or year [updated date - year month day; cited date - year month day]. Available from: URL
*** Download prepared Endnote style of JCBioR by clicking Here ***
Tables and Figures:
Tables and figures must be cited in order which they appear in the text, using Arabic numerals (Table 1, Figure 1). All tables and figures must appear on separate pages at the end of the manuscript. Tables should be simple and should not duplicate information in the main text. Do not submit tables as a snapshot. Figures should be provided only if they add further information. Legends for all figures should be included in the main file with the text. Acceptable formats for figures are JPEG or TIFF with a minimum resolution of 300 dpi.
Supplementary:
Supplementary files in any format will be freely available online, but it is recommended that to use common format files. Supplementary files must be cited in order which they appear in the text as Supplementary file 1, 2, etc.
Authorship:
The corresponding author is responsible to confirm that all of the listed authors have read and approved the final version of the submitted manuscript. Also, the corresponding author should ensure that the listed authors have made a substantive contribution to the article. The authors’ contributions must be declared in the “Authors' contributions” section. All contributors who did not meet the criteria for authorship should be listed in the “Acknowledgements” section.
Please note that authors do not permit changing the authorship after acceptance of a manuscript. Any change in authorship after initial submission must be provided by sending a letter to the editorial office described celery the reason(s) of any alterations and signed confirmation of all authors. The editorial office may ask authors to confirm their responses directly via email.
Funding:
All sources of funding and the role of the sponsor(s) for the research should be declared under a separate heading entitled “Funding”.
Conflicts of interest:
Authors must fully declare any existing or potential conflicts of interest of a financial, personal, or any other nature that could affect or bias their research. If there is no declaration, please include ‘None Declared’.
Human and animals rights:
All manuscripts concerning clinical investigations with humans or human materials must have been performed in accordance with the Declaration of Helsinki and should include a statement confirming that all subject or subject’s guardian provided written consent before participation after adequate explanation. Also, all studies must include a statement that the project was approved by the local Ethical Committee. Any reasons for waiving to obtain informed consent must be clearly declared.
All manuscripts reporting the results of experimental investigations involving animals are required to give an assurance statement that the animals were cared for in accordance with a standard guide to the care and use of experimental animals and must include a statement that their use of animals and experiments was reviewed and approved by the local Ethical Committee.
If the submitted article reports the results of a health care intervention on human participants (a clinical trial study), it is mandatory to have a registration number from a public trials registry that allows free online access to the public.
The Ethical Editor of JCBR is responsible to ensure the availability of ethical requirements at any stage of publication.
Article-processing and publication charge:
Journal of Current Biomedical Reports provide Open Access and freely available contents, immediately upon publication. This is made possible by charging a fixed article-processing charge (APC) for each accepted article since July 1, 2021 (Iranian authors only).
APC will be billed to the corresponding author upon editorial acceptance and before publication. These fees cover a range of publishing services includes providing and maintaining online tools, processing the manuscripts, connecting with abstracting and indexing services, plagiarism check, and providing DOI. No submission charges or color image charges exist apart from the APC.
We will consider waivers or discounts in cases of genuine need. Therefore, authors who are not able to pay the APC, are encouraged to contact the journal by sending an email to admin@jcbior.com to explain their reasons. To apply for a waiver please request after editorial acceptance. A decision on the waiver will normally be made within two working days.
Currently, publication in JCBR is free of charge for non-Iranian authors, and there are no submission or publication charges. Also, there is no fee for using color images.
For any specific inquiry, please contact the Journal via Email.